Cytokine mediators of septic infections in the normal and granulocytopenic host
- 1 May 1993
- journal article
- review article
- Published by Wiley in European Journal of Haematology
- Vol. 50 (5), 243-249
- https://doi.org/10.1111/j.1600-0609.1993.tb00156.x
Abstract
Cytokines presently known to be involved in systemic bacterial infection are tumour-necrosis factor (TNF), interleukin (IL)-1, IL-6, IL-8 and interferon-gamma (IFN-gamma) and the counterregulatory molecules soluble TNF receptor (sTNFR) and IL-1 receptor antagonist (IL-1 Ra). In animal models TNF, IL-1 and IFN-gamma mediate organ damage, low blood pressure and fatality, whereas IL-6 is involved in infection-related manifestations, like the production of acute-phase protein and fever, and IL-8 is chemotactic to granulocytes. TNF and IL-1 increase expression of adhesion molecules on endothelial cells and influence a number of components of the haemostatic system in favour of coagulation. The presence of cytokines in the circulation is characterized by sequential releases of TNF, IL-1 and IL-6/IL-8; however, many variations of this pattern exist during human infection. In experiments as well as in human infection TNF, IL-1, IL-6, IL-8 and IFN-gamma have been detected, and levels of TNF, IL-6 and IL-8 have been found to be associated with the severity of the disease. Collectively, TNF, IL-1 and IFN-gamma emerge as mediators of systemic infection and septic shock whereas IL-6 and IL-8 are related to other manifestations of infection. Counteracting molecules like sTNFR are released after somewhat of a delay following TNF and IL-1Ra is released concomitantly with IL-1. Probably these factors modulate the cytokine effect although their true potency in natural infection has yet to be clarified. In granulocytopenic infections TNF, IL-1, IL-6 and IL-8 can be detected in serum, and levels of TNF and IL-6 are even higher than in the normal situation in experimental animals. Antibodies to TNF inhibit bacteria-induced fatality in granulocytopenic mice. Altogether, few data related to the granulocytopenic situation are available. However, it is reasonable to believe that the altered development of granulocytopenic infections is due to changes in the cellular constitution and not to changes in cytokine production.Keywords
This publication has 60 references indexed in Scilit:
- Cytokine and Acute-Phase Reactant Levels in Serum of Children with Cancer Admitted for Fever and NeutropeniaThe Journal of Infectious Diseases, 1992
- Role of Interferon- in Experimental Gram-Negative SepsisThe Journal of Infectious Diseases, 1992
- Cytokine-associated tissue injury and lethality in mice: A comparative studyClinical Immunology and Immunopathology, 1991
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsNew England Journal of Medicine, 1990
- Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivoClinical Immunology and Immunopathology, 1989
- Interleukin 1-induced pathophysiology: Induction of cytokines, development of histopathologic changes, and immunopharmacologic interventionClinical Immunology and Immunopathology, 1989
- Native interleukin 1 inhibitorsImmunology Today, 1989
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasoneClinical Immunology and Immunopathology, 1987